Glimpses into treating GLILD

Timi Martelius; Mikko R J Seppänen

doi:10.1016/j.jaci.2023.06.010

Glimpses into treating GLILD

J Allergy Clin Immunol. 2023 Aug;152(2):365-367. doi: 10.1016/j.jaci.2023.06.010. Epub 2023 Jun 21.

Authors

Timi Martelius¹, Mikko R J Seppänen²

Affiliations

¹ Adult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and HUS Helsinki University Hospital; ERN-RITA Core Center, RITAFIN, Helsinki. Electronic address: timi.martelius@hus.fi.
² Adult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and HUS Helsinki University Hospital; ERN-RITA Core Center, RITAFIN, Helsinki; Rare Disease Center and Pediatric Research Center, Children and Adolescents, University of Helsinki and HUS Helsinki University Hospital; Translational Immunology Research Program, University of Helsinki.

PMID: 37352977
DOI: 10.1016/j.jaci.2023.06.010

No abstract available

Keywords: Interstitial lung disease; common variable; glucocorticoids; granulomatous-lymphocytic interstial lung disease; immunodeficiency; immunomodulatory therapy; inborn errors of immunity; primary immunodeficiencies.

Publication types

Editorial
Comment

MeSH terms

Common Variable Immunodeficiency*
Humans
Lung Diseases, Interstitial*